Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II - Clinical results

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 374-387

  Lauve, Andrew ^a   Morris, Monica ^a   Schmidt Ullrich, Rupert ^a   Wu, Qiuwen ^a   Mohan, Radhe ^d   Abayomi, Olubumni ^a   Buck, David ^a   Holdford, Diane ^a   Dawson, Kathryn ^a,c   Dinardo, Laurence ^b   Reiter, Evan ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Department of Otolaryngology ^*  (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dose escalation; Head and neck cancer; Intensity modulated radiotherapy; Simultaneous integrated boost

Indexed keywords

PATIENT TREATMENT; RADIATION; TISSUE; TOXICITY; TUMORS;

MAXIMAL TOLERABLE DOSE (MTD); SURVIVAL RATE; TUMOR CONTROL;

RADIOTHERAPY;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; FATIGUE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNX; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; OROPHARYNX TUMOR; PAIN; PAROTID GLAND; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAROTID GLAND; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 4544316285     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.03.010     Document Type: Article

References (46)

1. Morris M.M., Schmidt-Ullrich R.K., DiNardo L., et al. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 52:2002;918-928
2. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 19:1990;1339-1345
3. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial. Radiother Oncol. 44:1997;111-121
4. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003. Int J Radiat Oncol Biol Phys. 48:2000;7-16
5. Jackson S.M., Weir L.M., Hay J.H., et al. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 43:1997;39-46
6. Skladowski K., Maciejewski B., Golen M., et al. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - Report on 3-year tumour control and normal tissue toxicity. Radiother Oncol. 55:2000;101-110
7. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck The University of Florida experience. Head Neck. 15:1993;87-96
8. Overgaard J., Sand Hansen H., Overgaard M., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of the head and neck DAHANCA 6 and 7 randomized controlled trial. Lancet. 362:(9388):2003;933-940
9. Morris M.M., Schmidt-Ullrich R., Johnson C.R. Advances in radiotherapy for carcinoma of the head and neck. Surg Oncol Clin North Am. 9:2000;563-575
10. Mohan R., Wu Q., Manning M., et al. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 46:2000;619-630
11. Butler E.B., Teh B.S., Grant W.H. III, et al. SMART (simultaneous modulated accelerated radiation therapy) boost A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 45:1999;21-32
12. Wu Q., Mohan R. Algorithms and functionality of an intensity modulated radiotherapy optimization system. Med Phys. 27:2000;701-711
13. Wu Q., Manning M., Schmidt-Ullrich R., et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers A treatment design study. Int J Radiat Oncol Biol Phys. 46:2000;195-205
14. Wu Q., Mohan R., Morris M., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I Dosimetric results. Int J Radiat Oncol Biol Phys. 56:2003;573-585
15. Wu Q., Arnfield M., Tong S., et al. Dynamic splitting of large intensity-modulated fields. Phys Med Biol. 45:2000;1731-1740
16. Cooper J.S., Fu K., Marks J., et al. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys. 31:1995;1141-1164
17. Jha N., Seikaly H., Harris J., et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 66:2003;283-289
18. Mira J.G., Wescott W.B., Starcke E.N., et al. Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys. 7:1981;535-541
19. Valdez I.H., Atkinson J.C., Ship J.A., et al. Major salivary gland function in patients with radiation-induced xerostomia Flow rates and sialochemistry. Int J Radiat Oncol Biol Phys. 25:1993;41-47
20. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 45:1999;577-587
21. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 50:2001;695-704
22. Amosson C.M., Teh B.S., Van T., et al. SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost technique - Correlation of subjective xerostomia and dosimetric parameters of the parotid glands. Int J Radiat Oncol Biol Phys. 54:2002;18-19
23. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy Initial results. Int J Radiat Oncol Biol Phys. 49:2001;907-916
24. National Cancer Institute. The revised common toxicity criteria, version 2. CTEP Website: http://ctep.info.nih.gov/reporting/ctc.html
25. Radiation Therapy Oncology Group. RTOG H-0022, Phase I/II study of conformal and intensity modulated irradiation for oropharyngeal cancer. http://rtog.org/members/protocols/h0022/pdf.html
26. Varghese S., Schmidt-Ullrich R.K., Dritschilo A., et al. Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient. Radiat Oncol Invest. 7:1999;231-237
27. Morris M.M., Powell S.N. Irradiation in the setting of collagen vascular disease Acute and late complications. J Clin Oncol. 15:1997;2728-2735
28. Nowak P.J., Wijers O.B., Lagerwaard F.J., et al. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys. 45:1999;33-39
29. Som P.M., Curtin H.D., Mancuso A.A. The new imaging-based classification for describing the location of lymph nodes in the neck with particular regard to cervical lymph nodes in relation to cancer of the larynx. ORL J Otorhinolaryngol Relat Spec. 62:2000;186-198
30. Martinez-Monge R., Fernandes P.S., Gupta N., et al. Cross-sectional nodal atlas A tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology. 211:1999;815-828
31. Gregoire V., Coche E., Cosnard G., et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol. 56:2000;135-150
32. RTOG/EORTC late radiation morbidity scoring schema. RTOG Website. http://www.rtog.org/members/toxicity/late.html
33. Fox P.C., Busch K.A., Baum B.J. Subjective reports of xerostomia and objective measure of salivary gland performance. J Am Dent Assoc. 115:1987;581-584
34. Dorr W., Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol. 61:2001;223-231
35. Maciejewski B., Skladowski K., Pilecki B., et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer Preliminary report on acute toxicity. Radiother Oncol. 40:1996;137-145
36. Lee N., Chuang C., Quivey J.M., et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 53:2002;630-637
37. Johnson C.R., Schmidt-Ullrich R., Arthur D.W., et al. Standard once-daily versus thrice-daily concomitant boost accelerated superfractionated irradiation for advanced squamous cell carcinoma of the head and neck Preliminary results of a prospective randomized trial. [Abstract] Int J Radiat Oncol Biol Phys. 32:1995;162
38. Withers H.R., Taylor J.M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146
39. Tarnawski R., Fowler J., Skladowski K., et al. How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys. 54:2002;229-236
40. Kaanders J.H., van der Kogel A.J., Ang K.K. Altered fractionation Limited by mucosal reactions? Radiother Oncol. 50:1999;247-260
41. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122
42. Chao K.S., Low D.A., Perez C.A., et al. Intensity-modulated radiation therapy in head and neck cancers The Mallinckrodt experience. Int J Cancer. 90:2000;92-103
43. Hunt M.A., Zelefsky M.J., Wolden S., et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys. 49:2001;623-632
44. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 46:2000;1117-1126
45. Chao K.S., Ozyigit G., Tran B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 55:2003;312-321
46. Franzen L., Funegard U., Ericson T., et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck A consecutive study of salivary flow and patient discomfort. Eur J Cancer. 28:1992;457-462